Zhang VX, Suoangbaji T, Tsui YM, Sze KM, et al. Repurposing resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression. Hepatology 2026 Jan 12. doi: 10.1097/HEP.0000000000001675.
PMID: 41525571